Alphatec Holdings (ATEC) Osake Kurssi
Alphatec Holdings Kurssi
Viimeisten 19 vuoden aikana Alphatec Holdingsn liikevaihto kasvoi 13,1 % vuodessa ja ylsi 764,16 M USD:een. Alphatec Holdingsn nettomarginaali −18,8 % on noussut verrattuna −58,8 %:iin muutama vuosi sitten. Alphatec Holdingsn 12 kuukauden konsensustavoitehinta on 15,00 USD, noin yli kurssia 49,6 %. 21 analyytikosta 19 suosittaa ostoa — kokonaiskonsensus on Osta.
Alphatec Holdings osakekurssi
Alphatec Holdings liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Alphatec Holdings -osakkeesta
The business model of Alphatec Holdings Inc revolves around providing innovative solutions for the treatment of spinal disorders. As a leading medical technology company, Alphatec specializes in developing and commercializing products and services focused on improving patients' quality of life. They offer a comprehensive portfolio of spinal implants, surgical products, and biologics that are designed to enhance surgical outcomes and minimize complications. Alphatec's commitment to research and development, strategic partnerships, and continuous innovation has positioned the company as a trusted provider in the orthopedic industry. With a patient-centric approach, Alphatec aims to address the evolving needs of healthcare professionals and patients alike.
Alphatec Holdings Inc is primarily active in the medical technology industry.
The main competitors of Alphatec Holdings Inc in the market include Medtronic, Zimmer Biomet Holdings, NuVasive, and Stryker Corporation.
Alphatec Holdings Inc is a renowned company with a rich history and background. Founded in 1990, it has established itself as a leading provider of innovative spine surgery solutions. With a focus on design, development, and promotion of medical devices, Alphatec continues to revolutionize the field of spinal surgeries. Over the years, the company has expanded its product portfolio, offering a comprehensive range of implants, instruments, and bio-materials. Alphatec Holdings Inc has consistently aimed to improve patient outcomes through advanced technology and surgical expertise, making it a trusted name in the industry. With its extensive experience and commitment to innovation, Alphatec Holdings Inc has become a top choice for healthcare professionals and patients worldwide.
Some significant milestones achieved by Alphatec Holdings Inc include a successful completion of a merger with Solas BioVentures, a significant increase in revenues, and the development of innovative surgical solutions. Alphatec Holdings Inc has also gained FDA clearance for various products, expanding its market reach. Additionally, the company has forged strategic partnerships and collaborations, facilitating the advancement of its technologies and expanding its product portfolio. Alphatec Holdings Inc continues to demonstrate a commitment to innovation, growth, and improving patient outcomes in the field of spinal surgery.
Alphatec Holdings Inc is primarily present in the United States of America.
Alphatec Holdings Inc represents values of innovation, collaboration, and excellence. The company is committed to advancing spinal fusion technology and providing innovative and quality solutions to patients and surgeons worldwide. With a mission to improve patients' lives, Alphatec Holdings Inc focuses on developing minimally invasive surgical techniques and products that result in enhanced clinical outcomes. Through strategic partnerships and a strong dedication to research and development, the company continuously drives advancements in spinal surgery. Alphatec Holdings Inc's corporate philosophy is centered around patient-centricity, continuous improvement, and delivering value to stakeholders.
Analyytikot asettavat tällä hetkellä Alphatec Holdings-osakkeelle keskimääräisen tavoitehinnan 16,22 USD (mediaani: 15,00 USD), mikä merkitsee +61,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 21 analyytikkoarvioon.
21 analyytikkoa arvioi tällä hetkellä Alphatec Holdings-osaketta: 19 suosittaa ostoa, 2 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Alphatec Holdings-yhtiöltä 882,06 M USD liikevaihtoa ja 0,33 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Alphatec Holdings-osake noteerataan hintaan 8,92 EUR (10,03 USD).
Alphatec Holdings-osake (ATEC) on listattuna 3 pörssissä, muun muassa: NASDAQ (ATEC), Frankfurt (L1Z1.F), München (L1Z1.MU).
Alphatec Holdings Inc is a leading provider of innovative medical devices and instruments for spinal and neurosurgery. The company is divided into multiple business segments that focus on different aspects of the business. One of Alphatec's main business areas is the development and manufacturing of spinal systems. These products are used by orthopedic surgeons and neurosurgeons in surgeries to treat spinal injuries and disorders. The range includes implants, connecting elements, and instruments that enable surgeons to perform precise and effective procedures. Another important business segment of Alphatec is the development of technologies to support spinal and nervous system surgeries. This includes a wide range of products, such as imaging systems, nerve stimulators, and neuromonitoring devices. These technologies assist surgeons in performing surgical procedures more accurately and safely, thereby minimizing the risk of complications. Alphatec also has an extensive research and development department that continuously produces new products and technologies. In recent years, the company has developed several groundbreaking products, such as the Inlessis implant family, which offer significantly higher stability and effectiveness compared to conventional implants. To complement its offerings, Alphatec also provides a comprehensive range of education and training programs for surgeons and operating room personnel. These trainings help improve the knowledge and skills of medical professionals in the field of spinal surgery, thereby increasing their success rates. To drive its business forward, Alphatec has established a strong presence in several key markets. The company operates in over 50 countries worldwide and has a strong market position in North America, Europe, and Asia. Through targeted strategic partnerships and acquisitions, Alphatec is able to expand its reach and offerings. In summary, Alphatec Holdings Inc is an innovative provider of medical devices and instruments for spinal and neurosurgery. With its wide range of products, technologies, and trainings, the company has achieved a strong position in the market and is well-positioned for future growth.
odotettu liikevaihto Alphatec Holdings on 882,06 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Alphatec Holdings on 49,02 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Alphatec Holdings:n hinta-voitto-suhde (P/E) on tällä hetkellä 30,71. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Alphatec Holdings-osakkeen arvostusta.
Alphatec Holdings:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,71. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Alphatec Holdings-osakkeen arvostuskennuslukuna.
Alphatec Holdings:n Eulpool-laatuscore on 4/10.
Alphatec Holdings:n ISIN on US02081G2012. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Alphatec Holdings:n WKN on A2AP5V. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Alphatec Holdings:n ticker on ATEC. Tämä pörssinoteeraus käytetään Alphatec Holdings-osakkeiden kauppaan pörssissä.
Alphatec Holdings osake
Alphatec Holdings vertaisryhmä
Alphatec Holdings Ticker
Alphatec Holdings FIGI
Kaikki tunnusluvut ja syvällinen analyysi Alphatec Holdings:sta
Meidän osakeanalyysimme Alphatec Holdings-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Alphatec Holdings:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: